Report overview
This report contains market size and forecasts of Noninvasive Prenatal Gene Testing Technology in Global, including the following market information:
Global Noninvasive Prenatal Gene Testing Technology Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Noninvasive Prenatal Gene Testing Technology market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
NIPT Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Noninvasive Prenatal Gene Testing Technology include Illumina, Natera, LifeLabs, NiftyTest, Labcorp, Xcelom, Veritas, Sema4 and CeGaT, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Noninvasive Prenatal Gene Testing Technology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Noninvasive Prenatal Gene Testing Technology Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Noninvasive Prenatal Gene Testing Technology Market Segment Percentages, by Type, 2022 (%)
NIPT
NIPT Plus
Global Noninvasive Prenatal Gene Testing Technology Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Noninvasive Prenatal Gene Testing Technology Market Segment Percentages, by Application, 2022 (%)
Chromosomal Abnormalities
Assisted Reproduction
Others
Global Noninvasive Prenatal Gene Testing Technology Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Noninvasive Prenatal Gene Testing Technology Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Noninvasive Prenatal Gene Testing Technology revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Noninvasive Prenatal Gene Testing Technology revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Illumina
Natera
LifeLabs
NiftyTest
Labcorp
Xcelom
Veritas
Sema4
CeGaT
BGI
Berry Genomics
Daan Gene
CapitalBio
Annoroad
Adicon
